Filter
829
Filtered Results: 829
Text search:
European
Monitoring
Centre
for
Drugs
and
Drug
Addiction
Featured
Recommendations
73
New Publications
163
Language
Document type
No document type
498
Studies & Reports
146
Guidelines
106
Manuals
39
Strategic & Response Plan
19
Fact sheets
8
Situation Updates
6
Training Material
4
Resource Platforms
3
Countries / Regions
Western and Central Europe
69
Eastern Europe
31
Global
28
Ukraine
24
India
23
Sierra Leone
15
Kenya
15
Africa
14
Nepal
12
Zambia
12
Ghana
11
Russia
11
Nigeria
10
Uganda
10
Eastern Europe and Central Asia
10
Ethiopia
8
Myanmar / Burma
8
Albania
8
Cambodia
7
South Africa
7
Tajikistan
7
Liberia
6
Tanzania
6
Namibia
6
Latin America and the Carribbean
6
Asia
6
Burkina Faso
5
Rwanda
5
Bangladesh
5
Malawi
5
West and Central Africa
5
South–East Asia Region
5
Georgia
5
Senegal
4
Philippines
4
Syria
4
Laos
4
Moldova
4
Congo, Democratic Republic of
3
Zimbabwe
3
Pakistan
3
Jordan
3
Germany
3
Thailand
3
North Macedonia
3
Lesotho
3
East and Southern Africa
3
Morocco
2
South Sudan
2
Lebanon
2
Indonesia
2
Mozambique
2
Eswatini/ Swaziland
2
Botswana
2
Sri Lanka
2
Middle East and North Africa
2
Estonia
2
Kyrgyzstan
2
Vietnam
2
Guinea
1
USA
1
Saudi Arabia
1
Cameroon
1
Iraq
1
Afghanistan
1
Turkey
1
Ireland
1
Sudan
1
Benin
1
Argentina
1
Brazil
1
Serbia
1
Hungary
1
Colombia
1
Greece
1
Mexico
1
Western Pacific Region
1
Fiji
1
Bhutan
1
Poland
1
Armenia
1
Qatar
1
Bulgaria
1
Lithuania
1
Iran
1
Uzbekistan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Tunisia
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
186
Clinical Guidelines
89
Public Health
46
Women & Child Health
24
Key Resources
15
Pharmacy & Technologies
15
Capacity Building
6
Toolboxes
HIV
153
Mental Health
120
TB
103
AMR
68
Pharmacy
38
COVID-19
23
Rapid Response
19
Refugee
15
NCDs
15
Global Health Education
13
Conflict
12
Ebola
10
NTDs
10
Planetary Health
9
Disability
7
Caregiver
6
Polio
4
Specific Hazards
3
Health Financing Toolbox
3
Natural Hazards
1
Zika
1
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and ad...
Assessment and Guidance for Strengthening Integration of Mental Health into Primary Health Care and Community-Based Service Platforms in Ukraine
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microo...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
Barriers to HIV Services and Treatment for Persons with Disabilities in Zambia
The 80-page report documents the obstacles faced by people with disabilities in both the community ... healthcare settings. These include pervasive stigma and discrimination, lack of access to inclusive HIV prevention education, obstacles to accessing voluntary testing and HIV treatment, and lack of appropriate support for adherence to antiretroviral treatment. The report also describes the sexual and intimate partner violence women and girls with disabilities face, and the need for the government and international donors to do more to ensure inclusive and accessible HIV services.
The increasing global trend of Antimicrobial resistance (AMR) has gradually emerged as a major public health challenge for the entire world. AMR has spread to almost all countries and regions, inclu...
This Framework offers a coherent approach for eliminating tuberculosis (TB) in low-incidence countries. It is designed to guide national policy-makers and those responsible ... technical aspects of the national TB response in accelerating efforts towards elimination. The document will also be informative for public health surveillance officers, practitioners and nongovernmental and civil society partners working on natioal TB care and prevention and serving the populations most vulnerable to TB.
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data ... did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
Resistant bacteria are spreading worldwide. In collaboration with partners in India, Tanzania, South Africa and Germany, we have investigated the causes and consequences of this spread.2 This Pharma-Brief Special presents the results. It examines the risks for humans, animals and the environment. It focuses on local problems and approaches, international interactions and the re-sponsibility of doctors, farmers and consumers.
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new r...
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group al...
School health programmes have been demonstrated to be the most cost-effective way to influence health behaviours in young people. The purpose of this two-part handbook is to support schools as they seek to implement interventions aimed at reducing the main modifiable risk behaviours <... noncommunicable diseases (NCDs) . The background provided in this Introduction handbook and the approaches and advice outlined in the Practical application handbook focuses on providing young people with the knowledge, attitudes, beliefs and life skills necessary for making informed decisions, and creating a healthy school environment that can reduce the risk of NCDs
This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing thirty key questions about PrEP ... how it might be implemented in the UK.
This FY 2019 Malaria Operational Plan presents a detailed implementation plan for Burkina Faso, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in co...
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people ... kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action outlines a conceptual framework in which advantageously positioned digital health solutions are matched to the most urgent needs of TB programmes. Video-supported treatment is a component of one of the four core functions of this framework, the Patient Care domain, and primarily supports the first pillar of the End TB Strategy. This quick guide provides information on the solutions available for asynchronous modes of video communication and how these can be of use to TB programmes.
The global burden of disease due to mental disorders continues to rise, especially in low- and middle-income countries (LMIC). In addition to causing a large proportion of morbidity, mental disorder...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available informa...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and...
State of Health in the EU Cycle.
With the coronavirus (COVID-19) once again spreading rapidly, and the re-introduction of containment measures to flatten the curve of the epidemic, it is crucial for...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics ... vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the fact that the genetic sequence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had been shared worldwide. It was noted that in one country SARS-CoV-2 had been reconstructed in a laboratory from the viral genome sequence before the first case of COVID-19 had been reported, highlighting the benefits of synthetic biology technologies for accelerated development of diagnostics as well as the oft-described potential risks. Lessons learned about clinical care during the COVID-19 pandemic were also discussed.
